TheEdgeResearch
Home / Stocks / CYBQF

CYBERDYNE Inc. (CYBQF)

OTC Healthcare Medical - Devices
$1.24 ▲ +0.00%
Market Cap
$165.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.84
52-Wk Range
1.07-2.05
CEO
Yoshiyuki Sankai
Country
JP
Currency
USD

CYBERDYNE Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Tsukuba, IB, JP. The stock last traded at $1.24, up 0.00% on the session, giving a market capitalisation of $165.5M. On trailing twelve-month figures it carries a trailing P/E of 331.94, a net margin of 4.0%. Its beta of 0.84 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
331.94
Price / Sales
8.29
Price / Book
1.27
EV / EBITDA
-47.78
Gross margin
46.9%
Operating margin
-28.7%
Net margin
4.0%
Return on equity
Debt / equity
0.01
Current ratio
14.31
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
203
IPO date
2017-10-02
Headquarters
Tsukuba, IB, JP
About CYBERDYNE Inc.

CYBERDYNE Inc., founded in 2004 and headquartered in Tsukuba, Japan, is a multifaceted company involved in the entire product lifecycle—from research and development to production, sales, leasing, and maintenance—of advanced equipment and systems for both medical and defense applications within Japan. A cornerstone of their offerings is the Hybrid Assistive Limb (HAL) technology. This includes medical versions designed for lower limb and single joint rehabilitation, as well as non-medical variants providing assistance for lower limbs, single joints, and the lumbar region. They also produce various HAL peripherals. Beyond human augmentation, CYBERDYNE develops diverse robotic solutions, such as autonomous cleaning robots and transportation robots engineered for internal logistics across factories, offices, and other indoor environments. Another innovative product is Acoustic X, a high-speed LED array light source that facilitates real-time photoacoustic imaging. Their service portfolio features Cybernics Treatment, which leverages HAL to restore or enhance functional capabilities for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular diseases. They also provide HAL FIT, a program focused on improving the brain-nerve-musculoskeletal system; MTX Neuro HAL Plus, tailored to boost athletes' brain-nerve functions; and Neuro HALFIT, aimed at general physical function enhancement. Additionally, CYBERDYNE extends its expertise to societal support, assisting with disaster relief operations and providing heavy labor support for industrial plants and factories. The company also maintains a presence in the entertainment sector.

Comparable companies

CYBERDYNE Inc. is most often compared with the following Healthcare names:

BCCOYBRSYFCHHHFCLLKFJWCTFMFCSFNGENFRLLVFVMTHFYOURF
More research on CYBQF
CYBQF technical analysis CYBQF TheEdge Score Compare against peers
Open full interactive analysis & DCF →